We have found that a well-characterized P2X7 receptor antagonist AZ11645373 blocked production of pro-inflammatory chemokine IL-8 in endothelial cells treated with OxPAPC. The effect was not due to toxicity of AZ11645373 as documented by cellular metabolic activity assay. The mechanism of inhibition by AZ11645373 was apparently independent of the P2X7 receptor because this receptor was not involved in induction of IL-8 under our experimental conditions. In support of this notion, two P2X7 agonists ATP and BzATP did not upregulate IL-8. On the other hand, a chemically different P2X7 receptor antagonist A740003 did not inhibit OxPAPC-induced production of IL-8. The inhibitory action of AZ11645373 was observed at the level of IL-8 protein and messenger RNA (mRNA) induction. Furthermore, AZ11645373 inhibited induction of mRNA encoding for COX-2 (PTGS2) suggesting that its anti-inflammatory potential is not limited to suppression of IL-8 production. In addition to inhibiting stimulation by OxPAPC, AZ11645373 suppressed induction of IL-8 by TNFα and LPS. To summarize, AZ11645373 inhibits in a P2X7-independent manner action of chemically different inflammatory agonists such as OxPLs, LPS, and TNFα. Thus, AZ11645373 may be especially effective for treatment of inflammatory disorders due to a beneficial combination of P2X7 receptor-dependent effects (inhibition of inflammasome activation, antinociceptive effects) with P2X7-independent general anti-inflammatory action described in this paper.
He, Y., H. Hara, and G. Nunez. 2016. Mechanism and regulation of NLRP3 inflammasome activation. Trends in Biochemical Sciences. doi: 10.1016/j.tibs.2016.09.002 .
Prochnicki, Tomasz, Matthew S. Mangan, and Eicke Latz. 2016. Recent insights into the molecular mechanisms of the NLRP3 inflammasome activation. F1000Res 5. doi: 10.12688/f1000research.8614.1 .
Watson, A.D., N. Leitinger, M. Navab, K.F. Faull, S. Horkko, J.L. Witztum, W. Palinski, et al. 1997. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. The Journal of Biological Chemistry 272(21): 13597–13607. CrossRefPubMed
Pfaffl, M.W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 29(9): 45e–45. CrossRef
Bochkov, V.N., O.V. Oskolkova, K.G. Birukov, A.-L. Levonen, C.J. Binder, and J. Stockl. 2010. Generation and biological activities of oxidized phospholipids. Antioxidants & Redox Signaling 12(8): 1009–1059. CrossRef
Yeh, M., N. Leitinger, R. de Martin, N. Onai, K. Matsushima, D.K. Vora, J.A. Berliner, T. Srinivasa, and Reddy. 2001. Increased transcription of IL-8 in endothelial cells is differentially regulated by TNF- and oxidized phospholipids. Arteriosclerosis, Thrombosis, and Vascular Biology 21(10): 1585–1591. CrossRefPubMed
Roebuck, K.A. 1999. Regulation of interleukin-8 gene expression. Journal of Interferon & Cytokine Research 19(5): 429–438. CrossRef
Yeh, M., N.M. Gharavi, J. Choi, X. Hsieh, E. Reed, K.P. Mouillesseaux, A.L. Cole, S.T. Reddy, and J.A. Berliner. 2004. Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-src/signal transducers and activators of transcription (STAT)3 pathway. The Journal of Biological Chemistry 279(29): 30175–30181. CrossRefPubMed
Gharavi, N.M., J.A. Alva, K.P. Mouillesseaux, C. Lai, M. Yeh, W. Yeung, J. Johnson, et al. 2007. Role of the Jak/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo. The Journal of Biological Chemistry 282(43): 31460–31468. CrossRefPubMed
Gargalovic, P.S., M. Imura, B. Zhang, N.M. Gharavi, M.J. Clark, J. Pagnon, W.-P. Yang, et al. 2006. Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids. Proceedings of the National Academy of Sciences of the United States of America 103(34): 12741–12746. CrossRefPubMedPubMedCentral
Lee, H., W. Shi, P. Tontonoz, S. Wang, G. Subbanagounder, C.C. Hedrick, S. Hama, et al. 2000. Role for peroxisome proliferator-activated receptor in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circulation Research 87(6): 516–521. CrossRefPubMed
- Off-Target Anti-Inflammatory Activity of the P2X7 Receptor Antagonist AZ11645373
Olga V. Oskolkova
Valery N. Bochkov
- Springer US
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II